STEMPOINT CAPITAL
StemPoint looks to exploit the growing characteristics of the biotechnology sector and the protective attributes of the pharmaceutical industry.
Similar Organizations
EnviroKure, Incorporated
Disruptive ag biotechnology to enhance plant growth and productivity, builds healthy soil and can reduce the need for chemical fertilizers.
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Vallon Pharmaceuticals
Vallon Pharmaceuticals is a clinical-stage biopharmaceutical company.
Investors List
Leucadia Asset Management
Leucadia Asset Management investment in Venture Round - StemPoint Capital
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-04-05 | Protara Therapeutics | StemPoint Capital investment in Post-IPO Equity - Protara Therapeutics | 45 M USD |
| 2024-04-01 | Surrozen | StemPoint Capital investment in Post-IPO Equity - Surrozen | 17.5 M USD |
| 2024-02-27 | Pyxis Oncology | StemPoint Capital investment in Post-IPO Equity - Pyxis Oncology | 50 M USD |
| 2024-01-22 | Dianthus Therapeutics | StemPoint Capital investment in Post-IPO Equity - Dianthus Therapeutics | 230 M USD |
| 2023-12-15 | AC Immune | StemPoint Capital investment in Post-IPO Equity - AC Immune | 50.05 M USD |
| 2023-10-19 | Tourmaline Bio | StemPoint Capital investment in Post-IPO Equity - Tourmaline Bio | 75 M USD |
More informations about "StemPoint Capital"
StemPoint Capital
StemPoint Capital LP 520 Madison Avenue, 19th Floor New York, NY 10022 [email protected]See details»
StemPoint Capital - Crunchbase Investor Profile
StemPoint Capital invests in post-IPO equity in biotechnology, healthcare, and therapeutics sectors, focusing on North American hubs like New York, South San Francisco, and Boston. Learn More. Similar Investments. Talkiatry . Atalanta …See details»
StemPoint Capital Announces Strategic Relationship with Leucadia …
Jan 19, 2023 Media Inquiries: StemPoint Capital Sean Tan 212-540-4099 [email protected] Leucadia Asset Management / Jefferies Financial Group …See details»
STEMPOINT CAPITAL LP Top 13F Holdings - WhaleWisdom.com
Dec 31, 2024 Stempoint Capital is a large advisory firm with 4 clients and discretionary assets under management (AUM) of $440,900,000 (Form ADV from 2025-01-02). Their last reported …See details»
STEMPOINT CAPITAL LP | Form ADV - Radient
Jan 2, 2025 StemPoint Capital LP is an investment management firm based in New York, founded in 2022 by Managing Partners Michelle Ross and Sean Tan. The firm provides …See details»
StemPoint Capital - Investments, Portfolio & Company Exits
StemPoint Capital 's most notable exits include Tectonic Therapeutic, Pyxis Oncology, and Tourmaline Bio. Which industries has this organization had the most exits in? Show . Tectonic …See details»
Hedge Fund - StemPoint Capital - Insider Monkey
StemPoint Capital - Michelle Ross assets under management (13F Holdings), latest news, 13D/G filings, and investor letters provided by Insider MonkeySee details»
StemPoint Capital - Funding, Financials, Valuation & Investors
Jan 19, 2023 StemPoint Capital has raised 1 round. This was a Venture - Series Unknown round raised on Jan 19, 2023 . StemPoint Capital is funded by Leucadia Asset Management .See details»
9AT: STEMPOINT CAPITAL LP - Summary
Jan 2, 2025 Venture Capital Fund-Other Fund-Total Private Fund GAV 51.4m: AUM 174.4m: #Funds 4: Adviser SILVER CREEK CAPITAL MANAGEMENT LLC: Hedge Fund 364.0m: …See details»
StemPoint Capital - Products, Competitors, Financials, Employees ...
StemPoint Capital LP grew its position in Fulcrum Therapeutics by 8.1% in the first quarter. StemPoint Capital LP now owns 407,108 shares of the company’s stock valued at $3,843,000 …See details»
StemPoint Capital Announces Strategic Relationship with Leucadia …
Jan 19, 2023 About StemPoint Capital. StemPoint was founded and officially launched on January 3, 2023, by Michelle Ross, the Chief Investment Officer and Managing Partner. …See details»
STEMPOINT CAPITAL LP - 13F
Stempoint Capital LP reported 54 holdings with total value $401 M as of Q4 2024. Top holdings included SNDX, ROIV, IMVT, MRUS, and CRNX. STEMPOINT CAPITAL LP 13F Portfolio …See details»
StemPoint Capital Announces Strategic Relationship with ... - Yahoo
NEW YORK, January 19, 2023--StemPoint Capital LP ("StemPoint"), a long-biased equity asset management firm dedicated to the global life sciences industry, today announced that it has …See details»
Jefferies' Leucadia acquires stake in StemPoint Capital
Jan 20, 2023 Leucadia Asset Management, a division of Jefferies Financial Group, has acquired a minority interest in StemPoint Capital, which targets global life sciences …See details»
StemPoint Capital Announces Strategic Relationship with Leucadia …
Jan 19, 2023 About StemPoint Capital. StemPoint was founded and officially launched on January 3, 2023, by Michelle Ross, the Chief Investment Officer and Managing Partner. …See details»
Stempoint Capital LP - AUM 13F
Track the AUM, funds, and holdings for Stempoint Capital LP over time. View the latest funds and 13F holdings. Compare against similar firms.See details»
Stempoint Capital Lp 13F Portfolio - HedgeFollow
Fund Portfolio Manager Performance 24Q4 AUM # of Holdings Performance Rank Allocation ; Stempoint Capital Lp: Stempoint Capital Lp-14.21%: $399637000: 48: N/ASee details»
Stempoint Capital 13F filings and top holdings and stakes - stockzoa
SEC 13F filings are viewable for Stempoint Capital going back to 2024. Stempoint Capital 2024 Q3 filed Nov. 13, 2024 Stempoint Capital 2024 Q2 restated filed Aug. 13, 2024 Stempoint …See details»
StemPoint Capital Fund News | Hedge Fund Research
StemPoint Capital Fund Company Profile Company profile. Employees. Incorporated. Delaware. Location. New York. Industry. Hedge Fund. SEC CIK. 0001960394. IRS number. 920460297. …See details»
Stock Market | FinancialContent Business Page
Jan 19, 2023 About StemPoint Capital. StemPoint was founded and officially launched on January 3, 2023, by Michelle Ross, the Chief Investment Officer and Managing Partner. …See details»